Up­dat­ed: J&J builds out glob­al man­u­fac­tur­ing ca­pac­i­ty for CAR-T Carvyk­ti

John­son & John­son is ramp­ing up man­u­fac­tur­ing ca­pac­i­ty for the CAR-T ther­a­py it de­vel­oped with Leg­end Biotech, dri­ven by high de­mand for the Carvyk­ti, ex­ec­u­tives …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER